Insights › Sectors
Healthcare News Today
5 headlines on Healthcare cleared our tape in the last 7 days with a measured price reaction attached. 2 of them moved the underlying at least 0.35% in the minutes after it crossed. The largest measured reaction was +1.10% on MRNA at Sep 14, 10:39 ET.
Price action when the news broke
10:39:27 ET
What moved — last 7 days
| Time | Ticker | Headline | 1 min | Reaction |
|---|---|---|---|---|
| Sep 15, 10:51 ET | MRK | Gilead (GILD) anticipates launching next year its first islatravir-based weekly oral HIV treatment, aiming to move beyond Biktarvy in a market where roughly 20% of treated patients switch annually | -0.06% | -0.22% · 10m |
| Sep 15, 10:00 ET | DHR | According to Thermo Fisher (TMO), order volume is exceeding revenue, a sign that bodes well for future growthVolume 54.8K shares in 10 min | +0.04% | +0.01% · 10m |
| Sep 14, 11:45 ET | ABT | Abbott (ABT) has agreed to a settlement of more than USD 384mln over infant formula allegations, according to the US DoJ | -0.46% | -0.63% · 10m |
| Sep 14, 10:58 ET | PFE | Speaking at a conference, Pfizer (PFE) said it expects significant pipeline catalysts in 2027 and voiced strong confidence that longer-term growth will exceed current Street projections | -0.02% | +0.18% · 10m |
| Sep 14, 10:39 ET | MRNA | Moderna (MRNA) reaffirms plan to break even by 2028 with 2026 revenue growth of up to 10%Volume 214.8K shares in 10 min · 0.6× normal | +0.07% | +1.10% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Times are New York ET.
Our analysis
Why Is ENvue Medical Stock Down Today?
FEED fell before its reverse split became effective, showing that the market repriced the signal rather than the mechanical share conversion.
Why Is Pluri Stock Up Today?
PLUR rose on an equity offering because the $1.50 deal price stood above the pre-event market, though measured volume was thin.
Why Is Kazia Therapeutics Stock Down Today?
Kazia's initial offering announcement removed pricing certainty; the next-day terms separated $40 million of upfront proceeds from contingent warrants.
Why Is Celularity Stock Up Today?
Celularity's manufacturing collaboration produced a two-stage repricing, while the headline purchase opportunity remains conditional and multi-year.
Why Is Quoin Pharmaceuticals Stock Up Today?
QNRX rose after Quoin paired encouraging early QRX003 data with financing designed to extend its development runway.
Why Is Costco Stock Moving Today?
Costco is putting its name on Medicare plans with SCAN Health Plan — and federal rules bar the one thing it would most want to include.
Cardinal Health Beat by Half a Dollar, Added $5 Billion to Its Buyback, and Hit a 52-Week High
Cardinal Health closed fiscal 2026 with a fourth quarter that beat the profit estimate by a wide margin — non-GAAP EPS of $2.91 against a $2.42 …
Organogenesis Revenue Fell 58% After a CMS Reimbursement Change Gutted Its Wound-Care Business
Organogenesis reported Q2 2026 net revenue of $42.8 million, down 58% from $100.8 million a year earlier, as a CMS and Medicare reimbursement change disrupted its …
Why Is Envista Stock Up Today?
Envista is trading higher today, recovering part of yesterday's 14.3% drop that followed a quarter where the dental-products company beat both earnings and revenue estimates and …
Envista Beat Estimates and Raised Its Outlook. The Stock Fell 14% Anyway
Envista, the dental-products company behind DEXIS, Kerr, Nobel Biocare and Ormco, beat both earnings and revenue estimates on August 5, 2026 and raised its full-year outlook. …
Why Is Sight Sciences Stock Down Today?
SGHT is down on the session with no new company-specific headline today. The move follows an FDA-clearance pop the day before that has now fully unwound.
Sight Sciences Jumped 18% After Hours on an FDA Clearance. A Day Later It Was Below Where It Started.
Shares of the glaucoma-device maker spiked 18.5% within a minute of an FDA 510(k) clearance for its next-generation OMNI Ultra system. By the next session, the …
Why Is Amwell Stock Up Today?
A beat on both lines, but the real signal is a second straight quarter of narrowing losses on the path to positive cash flow.
AdaptHealth Q2 2026: A 17.6% Guidance Cut, and a GAAP Loss the Adjusted Number Didn't Show
AdaptHealth reported second-quarter 2026 results on August 4, 2026.
Why Is AdaptHealth Stock Down Today?
AdaptHealth's adjusted EPS was $0.08. Its GAAP EPS was a $0.99 loss. The stock fell 38.04% on the guidance cut underneath both.
Integer Holdings (ITGR): KKR Reported Near $4.3 Billion Buyout at $127 a Share
On July 31, 2026, the Wall Street Journal reported KKR was nearing a deal to acquire Integer Holdings at $127 a share, about $4.3 billion.
Why Is Integer Holdings Stock Up Today?
Integer Holdings jumped 20% after the Wall Street Journal reported KKR is nearing a deal to buy the medical-device manufacturer at $127 a share.